Author Question: An arrangement whereby a patient is allowed to leave the hospital, but must live in a halfway house ... (Read 37 times)

haleyc112

  • Hero Member
  • *****
  • Posts: 600
An arrangement whereby a patient is allowed to leave the hospital, but must live in a halfway house or other supervised setting and report to a mental health agency frequently is called
 
  a) outpatient commitment.
  b) conditional placement commitment.
  c) justified supervision of behavior commitment.
  d) none of the above.

Question 2

Anxiety often involves __________ arousal, and fear involves __________ arousal.
 
  a) high; low
  b) high; moderate
  c) moderate; low
  d) moderate; high



bhavsar

  • Sr. Member
  • ****
  • Posts: 351
Answer to Question 1

a

Answer to Question 2

d



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

This year, an estimated 1.4 million Americans will have a new or recurrent heart attack.

Did you know?

Certain chemicals, after ingestion, can be converted by the body into cyanide. Most of these chemicals have been removed from the market, but some old nail polish remover, solvents, and plastics manufacturing solutions can contain these substances.

Did you know?

An identified risk factor for osteoporosis is the intake of excessive amounts of vitamin A. Dietary intake of approximately double the recommended daily amount of vitamin A, by women, has been shown to reduce bone mineral density and increase the chances for hip fractures compared with women who consumed the recommended daily amount (or less) of vitamin A.

Did you know?

Pink eye is a term that refers to conjunctivitis, which is inflammation of the thin, clear membrane (conjunctiva) over the white part of the eye (sclera). It may be triggered by a virus, bacteria, or foreign body in the eye. Antibiotic eye drops alleviate bacterial conjunctivitis, and antihistamine allergy pills or eye drops help control allergic conjunctivitis symptoms.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library